August 21, 2007 / 8:16 PM / 10 years ago

Adnexus Therapeutics files for $86 million IPO

WASHINGTON, Aug 21 (Reuters) - Adnexus Therapeutics Inc. filed with regulators on Tuesday to raise up to $86.25 million in an initial public offering of common stock.

Lehman Brothers, UBS Investment Bank, Cowen and Co. and Lazard Capital Markets are underwriting the biotechnology company’s IPO, according to a registration statement with the U.S. Securities and Exchange Commission.

Adnexus plans to list its stock on the Nasdaq under the symbol “ADNX” ADNX.O.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below